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Abstract—This paper deals with an abstraction of a uni-
fied problem of drug discovery and pathogen identification.
Pathogen identification involves identification of disease-causing
biomolecules. Drug discovery involves finding chemical com-
pounds, called lead compounds, that bind to pathogenic pro-
teins and eventually inhibit the function of the protein. In
this paper, the lead compounds are abstracted as inhibitors,
pathogenic proteins as defectives, and the mixture of “ineffective”
chemical compounds and non-pathogenic proteins as normal
items. A defective could be immune to the presence of an
inhibitor in a test. So, a test containing a defective is positive
iff it does not contain its “associated” inhibitor. The goal of
this paper is to identify the defectives, inhibitors, and their
“associations” with high probability, or in other words, learn
the Immune Defectives Graph (IDG) efficiently through group
tests. We propose a probabilistic non-adaptive pooling design,
a probabilistic two-stage adaptive pooling design and decoding
algorithms for learning the IDG. For the two-stage adaptive-
pooling design, we show that the sample complexity of the
number of tests required to guarantee recovery of the inhibitors,
defectives, and their associations with high probability, i.e., the
upper bound, exceeds the proposed lower bound by a logarithmic
multiplicative factor in the number of items. To be precise, lower
and upper bounds of Ω ((r + d) logn+ rd) and O (rd logn)
tests respectively are identified for classifying r inhibitors and d
defectives amongst n items, and their associations. For the non-
adaptive pooling design, we show that the upper bound (given
by O((r + d)2 logn) tests) exceeds the proposed lower bound
(given by min
{
Ω ((r + d) logn+ rd) ,Ω
(
r2
log r
logn
)
,Ω
(
d2
)}
tests) by at most a logarithmic multiplicative factor in the number
of items.
I. INTRODUCTION
Preliminary stages of drug discovery involve finding
‘blocker’ or ‘lead’ compounds that bind to a biomolecular
target, which is a disease causing pathogenic protein, in order
to inhibit the function of the protein. Such compounds are later
used to produce new drugs. These lead compounds have to be
identified amidst billions of chemical compounds [1], [2], and
hence drug discovery is a tedious process. A complementary
problem involves identifying pathogenic proteins amidst non-
pathogenic ones, both of which are structurally identical in
some respects. For instance, out of five known species of
ebolavirus, only four of them are pathogenic to humans (see
p. 5 in [2]) and a similar example can be found in arenavirus
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[3]. Some of these pathogenic proteins might share a common
inhibitory mechanism against a lead compound which serves
to distinguish them from the non-pathogenic ones [3]. So,
finding potential pathogenic proteins amidst a large collection
of biomolecules by testing them against known inhibitory
compounds is a problem complementary to the problem of lead
compound discovery. The lead compounds can be abstracted as
inhibitor items, the pathogenic proteins as defective items, and
the others as normal items. Now, the above problems can be
combined to be viewed as an inhibitor-defective classification
problem on the mixture of pathogenic and non-pathogenic
proteins, and billions of chemical compounds. This unifies the
process of finding both the pathogenic proteins and the lead
compounds. An efficient means of solving this problem could
potentially be applied in high-throughput screening for drugs
and pathogens or computer-assisted drug and pathogen identi-
fication. A natural consideration is that, while some pathogenic
proteins might be inhibited by some lead compounds, other
pathogenic proteins might be immune to some of these lead
compounds present in the mixture of items. In other words,
each defective item is possibly immune to the presence of
some inhibitor items so that its expression cannot be prevented
by the presence of those inhibitors when tested together. By
definition, an inhibitor inhibits at least one defective. Learning
this inhibitor-defective interaction as well as classifying the
inhibitors and defectives efficiently through group testing is
presented this work.
A representation of this model, which we refer to as the
Immune-Defectives Graph (IDG) model, is given in Fig. 1.
The presence of a directed edge between a pair of vertices(
wik1 , wjk2
)
represents the inhibition of the defective wjk2 by
the inhibitor wik1 and the absence of a directed edge between
a pair of vertices
(
wik1 , wjk2
)
indicates that the inhibitor wik1
does not affect the expression of the defective wjk2 when
tested together. A formal presentation of the IDG model and
the goals of this paper appear in the next section.
Example 1: An instance of the IDG model is given in Fig.
2. In this example, the outcome of a test is positive iff a
defective wjk2 , for some k2, is present in the test and its
associated inhibitor wik2 does not appear in the test. Observe
that if the item-pair
(
wik1 , wjk2
)
, for k1 6= k2, appears in a
test and wik2 does not appear in the test, then the outcome
is positive. Also, if the item-pair
(
wik2 , wjk2
)
appears in a
test and if wjk′2
also appears in the test but not wik′2
, then
the test outcome is positive. But if the appearance of every
defective wjk′2
in a test is compensated by the appearance of
its associated inhibitor wik′2
in the test, then the test outcome
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2Fig. 1: A representation of the IDG Model, where I represents
the set of inhibitors and D represents the set of defectives.
is negative. The outcome of a test is also negative when none
of the defectives appear in a test.
Fig. 2: An example for the IDG Model where each defective
is associated with a distinct inhibitor so that r = d.
The IDG model can also be viewed as a generalization
of the 1-inhibitor model introduced by Farach et al. in [4].
This model was motivated by errors in blood testing where
blocker compounds (i.e., inhibitors) block the expression of
defectives in a test [5]. This is also motivated by drug dis-
covery applications where the inhibitors are actually desirable
items that inhibit the pathogens [6]. In the 1-inhibitor model,
a test outcome is positive iff there is at least one defective and
no inhibitors in the test. So, the presence of a single inhibitor
is sufficient to ensure that the test outcome is negative.
Efficient testing involves pooling different items together
in every test so that the number of tests can be minimized
[7]. Such a testing methodology is called group testing. The
pooling methodology can be of two kinds, namely non-
adaptive and adaptive pooling designs. In non-adaptive pooling
designs, any pool constructed for testing is independent of
the previous test outcomes, while in adaptive pooling designs,
some constructed pools might depend on the previous test
outcomes. A k-stage adaptive pooling design is comprised
of pool construction and testing in k-stages, where the pools
constructed for (non-adaptive) testing in the kth stage depend
on the outcomes in the previous stages. While adaptive group
testing requires lesser number of tests than non-adaptive
group testing, the latter inherently supports parallel testing
of multiple pools. Thus, non-adaptive group testing is more
economical (because it allows for automation) as well as
saves time (because the pools can be prepared all at once)
which are of concern in library screening applications [8]. The
1-inhibitor model has been extensively studied, and several
adaptive and non-adaptive pooling designs for classification
of the inhibitors and the defectives are known (refer, [9]–
[12]). A detailed survey of known non-adaptive and adaptive
pooling designs for the 1-inhibitor model is given in [13].
The best (in terms of number of tests) known non-adaptive
pooling design that guarantees high probability classification
of the inhibitors and defectives is proposed in [13]. The non-
adaptive pooling design proposed in [13] requires O(d log n)
tests in the r = O(d) regime and O
(
r2
d log n
)
tests in
the d = o(r) regime to guarantee classification of both the
inhibitors and defectives with high probability1. In the small
inhibitor, i.e., r = O(d) regime, the upper bound on the
number of tests matches with the lower bound while in the
large inhibitor, i.e., d = o(r) regime, the upper bound exceeds
the lower bound of O
(
r2
d log rd
log n
)
by a log rd multiplicative
factor. Nonetheless, the 1-inhibitor model constrains that every
inhibitor must inhibit every defective, which is likely to be a
tight requirement in practice. So, the IDG model is a more
practical variant of the 1-inhibitor model.
A formal presentation of the IDG model and the goals of
this paper are given in the next section.
Notations: The Bernoulli distribution with parameter p is
denoted by B(p), where p denotes the probability of the
Bernoulli random variable taking a value of one. The set of
binary numbers is denoted by B. Matrices are indicated by
boldface uppercase letters and vectors by boldface lowercase
letters. The row-i, column-j entry of a matrix M is denoted
by M(i, j), and the coordinate-i of a vector y is denoted by
y(i). All the logarithms in this paper are taken to the base
two. The probability of an event E is denoted by Pr{E}. The
notation f(n) ≈ g(n) represents approximation of a function
f(n) by g(n). Mathematically, the approximation denotes that
for every  > 0, there exists n0 such that for all n > n0,
1−  < |f(n)||g(n)| < 1 + .
II. THE IDG MODEL
Consider a set of items W indexed as w1, · · · , wn com-
prised of r inhibitors, d defectives, and n − r − d normal
items. It is assumed throughout the paper that r, d = o(n).
Definition 1: An item pair (wi, wj), for i 6= j, is said to be
associated when the inhibitor wi inhibits the expression of the
1The number of inhibitors, defectives and normal items are denoted by r,
d, and n− d− r respectively.
3defective wj . An item pair (wi, wj), for i 6= j, is said to be
non-associated if either the inhibitor wi does not inhibit the
expression of the defective wj or if wi is not an inhibitor or
if wj is not a defective.
In general, the mention of an item pair (wi, wj) need not mean
that wi is an inhibitor and wj is a defective. This is understood
from the context.
Definition 2: An association graph is a left to right directed
bipartite graph B = (I,D, E), where the set of vertices (on
the left hand side) I = {wi1 , wi2 , · · · , wir} ⊂ W denotes the
set of inhibitors, the set of vertices (on the right hand side)
D = {wj1 , wj2 , · · · , wjd} ⊂ W denotes the set of defectives,
and E is a collection of directed edges from I to D. A directed
edge e = (wi, wk) ∈ E , for i ∈ {i1, · · · , ir}, j ∈ {j1, · · · , jd},
denotes that the inhibitor wi inhibits the expression of the
defective wk.
We refer to E(I,D) conditioned on the sets (I,D) to be
the association pattern on (I,D).
A pooling design is denoted by a test matrix M ∈ BT×n,
where the jth item appears in the ith test iff M(i, j) = 1. A test
outcome is positive iff the test contains at least one defective
without any of its associated inhibitors. A positive outcome is
denoted by one and a negative outcome by zero.
It is assumed throughout the paper that the defectives are
not mutually obscuring, i.e., a defective does not function as
an inhibitor for some other defective. In other words, the set
of inhibitors I and the set of defectives D are disjoint.
The goal of this paper is to identify the association graph,
or in informal terms, learn the IDG. Thus, the objectives are
two-fold as represented by Fig. 3.
1) Identify all the defectives.
2) Identify all the inhibitors and also their association
pattern with the defectives.
Fig. 3: Here, the presence of a directed arrow represents an
association between an inhibitor and a defective. The problem
statement is to identify the set of inhibitors I, defectives D
and the association pattern E(I,D).
This problem is further mathematically formulated as follows.
Denote the actual set of inhibitors, normal items, and defec-
tives by I, N , and D respectively so that I ∪ N ∪ D = W .
The actual association pattern between the actual inhibitor and
defective sets is represented by E(I,D). Let Iˆ, Nˆ , Dˆ, and
Eˆ(Iˆ, Dˆ) denote the declared set of inhibitors, normal items,
defectives, and declared association pattern between (Iˆ, Dˆ)
respectively. The target is to meet the following error metric.
max
I,D,E(I,D)
Pr
{(
Iˆ, Dˆ, Eˆ
(
Iˆ, Dˆ
))
6= (I,D, E(I,D))
}
≤ cn−δ,
(1)
for some constants c, δ > 0. We propose pooling designs and
decoding algorithms, and lower bounds on the number of tests
required to satisfy the above error metric. It is assumed that
the defective and the inhibitor sets are distributed uniformly
across the items, i.e., the probability that any given set of
r+d items constitutes all the defectives and inhibitors is given
by 1
(nd)(
n−d
r )
. It is also assumed that the association pattern
E(I,D) is uniformly distributed over all possible association
patterns on (I,D).
We consider two variants of the IDG model. The first being
the case where the maximum number of inhibitors that can
inhibit any defective, given by Imax, is known. We refer to this
model as the IDG with side information (IDG-WSI) model.
For example, Fig. 2 represents a case where Imax = 1. While
it is known that Imax = 1, it is unknown which among the
items w1, · · · , wn represent which inhibitors and defectives.
For a given value of (r, d), not all positive integer values of
Imax ≤ r might be feasible. For instance, if (r, d) = (3, 2),
then Imax = 1 is not feasible because, by definition, each
inhibitor is associated with at least one defective. So, in the
IDG-WSI model, we assume that the given value of Imax is
feasible for the (r, d) tuple. In particular, if (c− 1)d < r ≤ cd
for some integer c ≥ 1, then Imax ≥ c. This immediately
follows from the fact that each inhibitor must be associated
with at least one defective.
The other variant of the IDG model we consider in this
paper is the case where there is no side information about
the inhibitor-defective associations, which means that each
defective can be inhibited by as many as r inhibitors. We
refer to this model as the IDG-No Side Information (IDG-
NSI) model. For both the models, the goals (as stated in the
beginning of this section) are the same.
The contributions of this paper for the IDG models are
summarized below.
• The sample complexity of the number of tests sufficient
to recover the association graph while satisfying the error
metric (1) using the proposed
– non-adaptive pooling design is given by
TNA = O
(
(r + d)2 log n
)
and TNA =
O
(
(Imax + d)
2 log n
)
tests for the IDG-NSI
and IDG-WSI models respectively (Theorem 1,
Section III).
– two-stage adaptive pooling design is given by TA =
O (rd log n) and TA = O (Imaxd log n) tests for the
IDG-NSI and IDG-WSI models respectively (Theo-
rem 2, Section III).
• In Section IV (Theorem 4 and Theorem 5), lower bounds
4of
max
{
Ω ((r + d) log n+ rd) ,Ω
(
r2
log r
log n
)
,Ω(d2)
}
,
max
{
Ω ((r + d) log n+ Imaxd) ,Ω
(
I2max
log Imax
log n
)
,
Ω(d2)
}
are obtained for non-adaptive pooling designs for the
IDG-NSI and IDG-WSI models respectively. The first
lower bounds for both the models are valid for adaptive
pooling designs also. The third lower bound for the IDG-
WSI model is valid under some mild restrictions on Imax
and r, the details of which are given in Theorem 5.
The pooling design matrix M constructed in this paper use
carefully chosen “random matrices”, i.e., the entries of the
matrices are chosen independently from a suitable Bernoulli
distribution. Such matrices are known to permit ease of analy-
sis [14]. Notwithstanding the simplicity of the pooling design
construction, figuring out a good decoding algorithm with a
reasonable computational complexity and good lower bounds,
especially for non-adaptive pooling designs, is a challenging
task. The goodness of the pooling design, decoding algorithm
tuple and the proposed lower bounds is measured in terms
of the closeness of the upper bounds to the lower bounds
on the number of tests. For non-adaptive pooling designs,
this can be observed from Table I. For the proposed adaptive
pooling design, the upper bound exceeds the lower bound by
at most a log n multiplicative factor for both IDG-NSI and
IDG-WSI models. Also, the proposed decoding algorithms
have a computational complexity of O(nTNA) and O(nTA)
time units for the non-adaptive and adaptive pooling designs,
respectively. This intuitively means that an item is “processed”
at most a constant number of times per test.
Extension of the results on the upper and lower bounds on
the number of tests to the case where only upper bounds on the
number of inhibitors (given by R) and defectives (given by D)
are known instead of their exact numbers is straightforward.
The target error metric in (1) is re-formulated as maximum
error probability criterion over all combinations of number of
inhibitors and defectives. The results for this case follow by
replacing r by R and d by D in the upper and lower bounds
on the number of tests.
There are various generalizations of the 1-inhibitor model
considered in the literature. These models are summarized in
the following sub-section to show that the model considered in
this paper, to the best of our knowledge, has not been studied
in the literature.
A. Prior Works
The 1-inhibitor model can be generalized in various direc-
tions, mostly influenced by generalizations of the classical
group testing model. The various generalizations are listed
below and briefly described. Though none of these generaliza-
tions include the model studied in this paper, it is worthwhile
to understand the differences between these models and the
IDG model.
A generalization of the 1-inhibitor model, namely k-
inhibitor model was introduced in [15]. In the k-inhibitor
model, an outcome is positive iff a test contains at least one
defective and no more than k − 1 inhibitors. So, the number
of inhibitors must be no less than a certain threshold k to
cancel the effect of any defective. This model is different
from the model introduced in this paper because, in the IDG
model, a single associated inhibitor is enough to cancel the
effect of a defective. Further, none of the inhibitors might be
able to cancel the effect of a defective because the defective
might not be associated with any inhibitor. A model loosely
related with the 1-inhibitor model, namely mutually obscuring
defectives model was introduced in [16]. Here, it was assumed
that multiple defectives could cancel the effect of each other,
and hence the outcome of a test containing multiple defectives
could be negative. Thus, a defective can also function as a
inhibitor. However, in this paper, the sets of defectives and
inhibitors are assumed to be disjoint. The threshold (classical)
group testing model is where a test outcome is positive if
the test contains at least u defectives, negative if it contains
no more than l defectives and arbitrarily positive or negative
otherwise [17]. This model was combined with the k-inhibitor
model and non-adaptive pooling designs for the resulting
model was proposed in [18].
A non-adaptive pooling design for the general inhibitor
model was proposed in [19]. Here, the goal was to identify
all the defectives with no prior assumption on the cancellation
effect of the inhibitors on the defectives, i.e, the underlying
unknown inhibitor model could be a 1-inhibitor, k-inhibitor
model, or even the ID model introduced in this paper. How-
ever, the difference from our work is that, we aim to identify
the association graph or, in other words, the cancellation effect
of the inhibitors also apart from identification of the defectives.
But this cancellation effect does not include the k-inhibitor
model cancellation effect as noted earlier. Group testing on
complex model was introduced in [20]. In the complex model,
a test outcome is positive iff the test contains at least one of
the defective sets. So, here the notion of defectives items is
generalized to sets of defective items called defective sets.
This complex model was combined with the general inhibitor
model and non-adaptive pooling designs for identification of
defectives was proposed in [21]. Our work is different from
[21] for the same reasons as stated for [19]. Group testing on
bipartite graphs was proposed in [22] as a special case of the
complex model. Here, the left hand side of the bipartite graph
represents the bait proteins and the right hand side represents
the prey proteins. It is known a priori which items are baits
and which ones are preys. The edges in the bipartite graph
represent associations between the baits and preys. A test
outcome is positive iff the test contains associated items and
the goal was to identify these associations. Clearly, this model
is different from the IDG because, in the IDG model, there
are three types of items involved and the interactions between
the three types of items are different from that in [22].
In the next section, we propose a probabilistic non-adaptive
and a probabilistic two-stage adaptive pooling design and
decoding algorithms for both the variants of the IDG model
discussed this section.
5TABLE I: Necessary and sufficient number of tests for various regimes of the number of inhibitors, defectives, and Imax are given. In the
large inhibitor regime, i.e., d = O(r) for the IDG-NSI model and d = O(Imax) for the IDG-WSI model, the upper bounds exceed the
lower bounds by multiplicative factors of log r and log Imax for the IDG-NSI and IDG-WSI models respectively. In the small inhibitor
regime, i.e., r = o(d) for the IDG-NSI model and Imax = o(d) for the IDG-WSI model, the upper bounds exceed the lower bounds by
multiplicative factors of logn for both IDG-NSI and IDG-WSI models.
Model d = O(r), d = O(Imax) (large inhibitor regime) r = o(d), Imax = o(d) (small inhibitor regime)
IDG-WSI Upper Bound: O
(
r2 logn
)
Upper Bound: O(d2 logn)
Lower Bound: Ω
(
r2
log r
logn
)
Lower Bound: Ω(d2)
IDG-NSI Upper Bound: O
(
I2max logn
)
Upper Bound: O(d2 logn)
Lower Bound: Ω
(
I2max
log Imax
logn
)
Lower Bound: Ω(d2)
III. POOLING DESIGNS AND DECODING ALGORITHM
In this section, we propose a non-adaptive pooling design
and decoding algorithm as well as a two-stage adaptive pooling
design and decoding algorithm for the IDG-WSI Model.
The pooling designs and decoding algorithms for the IDG-
NSI model follows from those for the IDG-WSI Model by
replacing Imax by r.
Non-adaptive pooling design: The pools are generated from
the matrix MNA ∈ BTNA×n. The entries of MNA are i.i.d. as
B(p1). Test the pools denoted by the rows of MNA. Let the
outcome vector be given by y ∈ BTNA×1. The exact value of
TNA is specified in (11) and (12) (where TNA = βNA log n)
in Sub-section III-A, and its scaling is given in Theorem 1
(which appears before the beginning of Sub-section III-A).
The exact value of p1 is also given in Theorem 1.
Adaptive pooling design: A set of pools are generated from
the matrix M1 ∈ BT1×n whose entries are i.i.d. as B(p1).
The pools denoted by the rows of M1 are tested first and all
the defectives are classified from the outcome vector y1 ∈
BT1×1. Denote the number of items declared defectives by
dˆ and the set of declared defectives by
{
uˆ1, uˆ2, · · · , uˆdˆ
}
. If
dˆ 6= d, an error is declared. We keep these declared defectives
aside and generate another pooling matrix M2 ∈ BT2×(n−d),
whose entries are i.i.d. as B(p2), for the rest of the items. Now,
test the pools denoted by the rows of the matrix M2 along
with each of the items declared defectives and the outcomes
are denoted by yuˆ1 ,yuˆ2 , · · · ,yuˆd ∈ BT2×1. The two stages
of testing are done non-adaptively as represented in Fig. 4,
and hence the pooling scheme is a two-stage adaptive pooling
design. The exact values of p1 and p2 are given in Theorem
2 (which appears before the beginning of Sub-section III-A).
The scaling of T1 and T2 are also given in Theorem 2 and their
exact values are given in (11) and (13) (where, Ti = βi log n).
The total number of tests is given by T1 + dT2.
The defectives are expected to participate in a higher
fraction of positive outcome tests than the normal items or
the inhibitors. And, once the defectives are identified, tests
of each one of them with rest of the items can be used to
determine their associations. We show that this can be done
non-adaptively as well. The decoding algorithm proceeds in
two steps for both non-adaptive and adaptive pooling design.
The first step will identify the defectives from the outcome
vectors y and y1 in the non-adaptive and adaptive pooling
designs respectively, according to the fraction of positive
 Test and identify 
defectives from 
Fig. 4: The proposed two-stage adaptive pooling design
scheme is demonstrated here. The symbol
⊕
indicates that
the pooling matrix M2 is tested along with the items uˆi which
are declared defectives. The items non-associated with uˆi are
determined from the outcome vector yui , for i = 1, 2, · · · , d.
outcome tests in which an item participates. The second step
will identify the inhibitors and their associations with the
declared defectives using subsets of the outcome vector y
in the non-adaptive pooling design and the outcome vectors
yuˆ1 ,yuˆ2 , · · · ,yuˆd in the adaptive pooling design.
Let us define the following notations2 with respect to the
pools represented by MNA and M1 which are eventually
useful in characterizing the statistics of the different types of
items that are used in the decoding algorithm.
Notations:
• I(u) denotes the set of inhibitors that the defective u is
associated with.
• Fuk denotes the event that none of the inhibitors associ-
ated with a defective uk appears in a test, given that the
defective uk appears in the test.
• D(j)i ⊆ P({u1, · · · , ud}) denotes the jth-set in the (arbi-
trarily) ordered set of all i-tuple subsets of the defective
set denoted by Di, for j = 1, · · · ,
(
d
i
)
, where ui denotes
a defective and P{(u1, · · · , ud)} denotes the power set
of the set of defectives.
• D(s) denotes the defectives associated with the inhibitor
2From hereon, we reserve the notation u to represent a defective, v to
represent a normal item and s to represent an inhibitor.
6s and its complement is given by D(s) = D −D(s).
• D(s)i denotes the (arbitrarily) ordered set of all i-tuple
subsets of the defective set D(s) and the jth-set in D(s)i
is denoted by D(s)(j)i .
Example 2: Realizations of the above notations for the
association graph in Fig. 2 considered in Example 1 are given
below. The inhibitor set is given by I = {s1, · · · , sr} ⊂ W
and the defective set is given by D = {u1, · · · , ud} ⊂ W with
r = d. An inhibitor si is associated with a distinct defective
ui, and so
• I(u) for u = ui is given by I(ui) = {si}.
• Fu1 represents the event that the inhibitor s1 associated
with the defective u1 does not appear in a test, given that
the defective u1 appears in the test.
• Realizations of Di for i = 1, 2 are given by
D1 = {{u1}, {u2}, · · · , {ud}} ,
D2 = {{u1, u2}, {u1, u3}, · · · , {u1, ud},
{u2, u3}, · · · , {u2, ud}, · · · , {ud−1, ud}} .
Realizations of D(j)i for (i, j) = (1, 2) and (i, j) = (2, 3)
are given by
D(2)1 = {u2},D(3)2 = {u1, u4}.
• D(s) for s = s1 is given by D(s1) = u1 and its
complement is given by D(s1) = {u2, · · · , ud}.
• Realizations of D(s)i for s = s1 and i = 1, 2
D(s1)1 = {{u2}, · · · , {ud}} ,
D(s1)2 = {{u2, u3}, {u2, u4}, · · · , {u2, ud},
{u3, u4}, · · · , {u3, ud}, · · · , {ud−1, ud}} .
Realizations of D(s)(j)i with s = s1, for (i, j) = (1, 2)
and (i, j) = (2, 3) are given by
D(s)(2)1 = {u3},D(s)
(3)
2 = {u2, u5}.
We now define the following statistics corresponding to the
different types of items. The following statistics also hold good
when y1 is replaced by y, as entries of both MNA and M1
have the same statistics.
q
(u)
1 , Pr
{
y1(l) = 1|defective u is present in the lth-test
}
≥ (1− p1)|I(u)| ≥ (1− p1)Imax , (2)
q
(v)
2 , Pr
{
y1(l) = 1|normal item v is present in the lth-test
}
=
d∑
i=1
pi1(1− p1)d−i
(di)∑
j=1
Pr

⋃
uk∈D(j)i
Fuk
 , q2 (3)
≤
d∑
i=1
pi1(1− p1)d−i
(
d
i
)
= 1− (1− p1)d , qUB2 , (4)
q
(s)
3 , Pr
{
y1(l) = 1|Inhibitor s is present in the lth-test
}
=
|D(s)|∑
i=1
pi1(1− p1)|D(s)|−i
|D(s)i|∑
j=1
Pr

⋃
uk∈D(s)(j)i
Fuk
 ,
(5)
if
∣∣∣D(s)∣∣∣ ≥ 1,
= 0, otherwise.
Since the outer and inner summations in (5) is over a subset
of those in (3), max
s
q
(s)
3 ≤ q(v)2 = q2. It is also intuitive that
positive outcome for an inhibitor in a test is less probable than
that for a normal item. The equality in (3) follows from the
fact that a test outcome is positive iff at least one defective
appears in the test (which is captured by the outer summation
term) and none of the inhibitors associated with at least one of
these defectives appears in the test (which is captured by the
union of the events Fuk over uk). A similar explanation holds
true for (5). The upper bound in (4) follows from the upper
bound of one on the probability terms of (3). In hindsight, the
lower bound in (2) and the upper bound in (4) can be easily
obtained as follows. The lower bound on the positive outcome
statistics for a defective item in (2) follows from the worst
case statistics when all the inhibitors inhibit the expression of
every defective. The upper bound on the statistics for a normal
item in (4) follows by using the best case positive outcome
statistics, in the absence of inhibitors, where the appearance
of any defective gives a positive test outcome. In the sequel,
we shall exploit the difference between (2) and (4) to identify
the defectives notwithstanding the fact the one of them could
be loose bounds for specific association graphs. For example,
(2) is tight for the 1-inhibitor model whereas (4) could be a
loose upper bound for the same association graph, depending
on the values of p, r, and d. However, fortunately, p1 can be
chosen appropriately so that the looseness in the bounds do not
affect the scaling of the upper bound on the number of tests
required to identify the defectives, and the dominant scaling
is determined by the number of tests required to identify the
association pattern.
Denote the worst case negative outcome statistic for a
defective by
bmax = 1− (1− p1)Imax . (6)
Denote the set of tests corresponding to outcome vector y
in which an item wj participates by Twj (y) and the set of
7positive outcome tests in which the item wj participates by
Swj (y), for j = 1, 2, · · · , n. The decoding algorithm is given
as follows.
1) Step 1 (Identifying the defectives for both non-adaptive
and adaptive pooling designs):
For the non-adaptive pooling design, if |Swj (y)| >∣∣Twj (y)∣∣ [1 − bmax(1 + τ))] with bmax as defined in
(6), declare the item wj to be a defective. For the
adaptive pooling design, we use the same criterion,
replacing y by y1. Denote the number of items declared
as defectives by dˆ and the set of declared defectives by{
uˆ1, uˆ2, · · · , uˆdˆ
}
. If dˆ 6= d, declare an error. Denote the
the remaining unclassified items in the population by{
w′1, · · · , w′n−d
}
, {w1, · · · , wn} − {uˆ1, · · · , uˆd}.
2) Step 2 (Identifying the inhibitors and their associations
for non-adaptive pooling design):
Let Pk denote the sets of pools in MNA that contain
only the declared defective uˆk and none of the other
declared defectives, for k = 1, · · · , d. Also, let the
outcomes corresponding to these pools be positive. This
means that the pools in Pk do not contain any inhibitor
from the set I(uˆk), which denotes the set of inhibitors
associated with the item uˆk if uˆk is indeed a defective.
Now, consider only the outcomes corresponding to these
pools denoted by yP1 ⊂ y, · · · ,yPd ⊂ y. The associa-
tions of the declared defectives are identified as follows.
• For each k = 1 to d, declare (w′j , uˆk) to be a non-
associated inhibitor-defective pair if w′j participates
in at least one of the tests corresponding to the
outcome vector yPk and declare the rest of the items
to be associated with uˆk.
The items declared as non-associated for all k are
declared to be be normal items. If Pk = {∅} for some
k, declare an error.
3) Step 2 (Identifying the inhibitors and their associations
for adaptive pooling design):
Let S(yuˆk) denote the set of positive outcome tests
corresponding to yuˆk , i.e., these pools do not contain
any inhibitor from the set I(uˆk) if uˆk is a defective.
• For each k = 1 to d, declare (w′j , uˆk) to be a non-
associated inhibitor-defective pair if w′j participates
in at least one of the tests in the set S(yuˆk) and
declare the rest of the items to be associated with
uˆk.
The items declared as non-associated for all k are
declared to be be normal items. If S(yuˆk) = {∅} for
some k, declare an error.
The following toy example demonstrates the operation of
the above decoding algorithm for non-adaptive pooling design.
Example 3: Consider the following non-adaptive pooling
design matrix MNA ∈ B5×5 and the outcome vector y ∈
B5×1 for the underlying association graph shown in Fig. 5. The
item w5 is a normal item. Here, r = d = 2, n = 5, TNA = 5.
Fig. 5: The underlying association graph for Example 3.
MNA =

1 1 0 0 1
0 1 0 1 0
0 1 1 0 1
1 0 0 1 1
0 0 1 1 1
⇒ y =

0
1
1
1
0

We recall that column-j of the matrix MNA corresponds to the
item wj . The threshold for identifying the defectives in Step 1
of the decoding algorithm is such that any item wj that satisfies
the condition
|Swj (y)|
|Twj (y)| >
1
2 is declared to be a defective. Now,
observe the operation of the decoding algorithm.
Step 1: We observe that
|Sw1(y)|
|Tw1(y)|
=
1
2
,
|Sw2(y)|
|Tw2(y)|
=
2
3
,
|Sw3(y)|
|Tw3(y)|
=
1
2
,
|Sw4(y)|
|Tw4(y)|
=
2
3
,
|Sw5(y)|
|Tw5(y)|
=
1
2
.
Items w2 and w4 are the only items that satisfy the condition|Swj (y)|
|Twj (y)| >
1
2 , and hence are declared defectives. Therefore,
the declared defectives are given by uˆ1 = w2, uˆ2 = w4 and
the remaining unclassified items are given by w′1 = w1, w
′
2 =
w3, w
′
3 = w5.
Step 2: The “useful” pools used for identifying the “non-
associations” are obtained as P1 = {3},P2 = {4}. This is
because the third test outcome in which uˆ1 participates and
uˆ2 does not participate is positive, and the fourth test outcome
in which uˆ2 participates and uˆ1 does not participate is also
positive. Since the items w′2 and w
′
3 participate in the third test,
(w′2, uˆ1) = (w3, w2) and (w
′
3, uˆ1) = (w5, w2) are declared
to be non-associated inhibitor-defective pairs and (w′1, uˆ1) =
(w1, w2) is declared to be an associated inhibitor-defective
pair. Similarly, (w′1, uˆ2) = (w1, w4) and (w
′
3, uˆ1) = (w5, w4)
are declared to be a non-associated item-pairs and (w′2, uˆ2) =
(w3, w4) is declared to be an associated inhibitor-defective
pair. Since the item w′3 = w5 is declared to be non-associated
with both uˆ1 and uˆ2, it is declared to be a normal item.
We emphasize that this is a toy example to demonstrate
the operation of the proposed decoding algorithm and not
representative of the values of p or τ or TNA for the given
values of r, d, n.
Remark 1: (Step 1) The first step in the decoding algorithm,
which is the same for both the non-adaptive and adaptive
pooling design, is similar to the defective classification al-
gorithm used in [13] for the 1-inhibitor model. The under-
lying common principle used is that there exists statistical
8difference between the defective items and the rest of the
items. Hence, with sufficient number of tests, the defectives
can be classified by “matching” the tests in which an item
participates and the positive outcome tests. The items involved
in a large fraction of positive outcome tests are declared
to be defectives. A similar decoding algorithm was used in
the classical group testing framework with noisy tests [23].
Here, the inhibitors of a defective item, if any, behave like
a noise due to probabilistic presence in a test. The (worst
case) expected number of positive outcome tests in which a
defective participates is at least |Twj (y)|[1 − bmax]. Like in
[13], the Chernoff-Hoeffding concentration inequality [24] is
used to bound the error probability and obtained the exact
number of tests required to achieve a target (vanishing) error
probability. It is important to note that, a priori, it is not clear
if a fixed threshold technique can sieve the defectives under
worst case positive outcome statistics and the rest of the items
under best case positive outcome statistics, with vanishing
error probability. The fact that this is indeed possible will
be proved in the following sub-section.
Remark 2: (Step 2) In the IDG model, the inhibitors for
each defective might be distinct. Hence, an inhibitor for one
defective behaves as a normal item from the perspective of
another defective. This defective-specific interaction is absent
in the 1-inhibitor model. So, any inhibitor can be identified
using any defective, i.e, an inhibitor’s behaviour is defective-
invariant in the 1-inhibitor model, which was exploited in iden-
tifying the inhibitors in [13]. Since each inhibitor’s behaviour
can be defective-specific in the IDG model, we need to identify
the defectives first and then identify its associated inhibitors
by observing the interaction of the other items with each of
these defectives.
The following theorems state the values of the parameters
p1, p2, and τ , and the scaling of the number of tests required
for the proposed non-adaptive and adaptive pooling designs to
determine the association graph with high probability. Similar
results can be stated for the IDG-NSI model by replacing Imax
by r in the following theorems.
Theorem 1 (Non-adaptive pooling design): Choose the
pooling design matrix MNA of size TNA × n with its entries
chosen i.i.d. as B(p1) with p1 = 13(Imax+d) for the IDG-WSI
model. Test the pools denoted by the rows of the matrix
MNA non-adaptively. The scaling of the number of tests
sufficient to guarantee vanishing error probability (1) using
the proposed decoding algorithm with τ = 1−bmax−q
UB
2
2bmax
is
given by TNA = O
(
(Imax + d)
2 log n
)
, where qUB2 and
bmax are defined in (4) and (6) respectively.
Theorem 2 (Adaptive pooling design): Choose the pooling
design matrices M1 and M2 of sizes T1×n and T2×n with
its entries chosen i.i.d. as i.i.d. B(p1) and B(p2) respectively,
with p1 = 13(Imax+d) and p2 =
1
2Imax
for the IDG-WSI
model. Test the pools denoted by the rows of the matrices
M1 non-adaptively and classify the defectives. Now, test each
of the pools from M2 along with the d classified defectives
individually. The scaling of the number of tests sufficient to
guarantee vanishing error probability (1) using the proposed
decoding algorithm with τ = 1−bmax−q
UB
2
2bmax
is given by
TA = T1 + dT2 = O (Imaxd log n), where qUB2 and bmax
are defined in (4) and (6) respectively.
Remark 3: The value of τ = 1−bmax−q
UB
2
2bmax
chosen in
the above theorems implies that the decoding algorithm de-
clares item wj to be a defective if
|Swj (y)|
|Twj (y)| ,
|Swj (y1)|
|Twj (y1)| >
(1−bmax)+qUB2
2 . This threshold is simply an average between
the worse-case positive outcome statistic for a defective and
the best-case positive outcome statistic for a normal item or
an inhibitor. The values of p and p1 are chosen so that the
former is greater than the latter.
The following sub-section constitutes the proof of the above
theorems. The exact number of tests required to guarantee
vanishing error probability for recovery of the association
graph are also obtained. The proof is exactly the same for
the IDG-NSI model, but replacing Imax by r.
A. Error Analysis of the Proposed Algorithm
As mentioned in Section II, we require that
max
I,D,E(I,D)
Pr
{
(I,D, E(I,D)) 6=
(
Iˆ, Dˆ, Eˆ(Iˆ, Dˆ
)}
≤ cn−δ,
for some constant c > 0 and fixed δ > 0. For the non-adaptive
pooling design, we find the number of tests TNA required
to upper bound the error probability of the first step of the
decoding algorithm by c1n−δ1 and that of the second step
of the decoding algorithm by c2n−δ2 , for some constants c1
and c2. A similar approach is taken for the two-stage adaptive
pooling design to find the number of tests T1 and the value of
T2. Finally, the values of δ1 and δ2 are chosen so that the total
error probability is upper bounded by cn−δ , for some constant
c and given δ > 0.
1) Error Analysis of the First Step: Since the first step of
the decoding algorithm is the same for both the non-adaptive
and adaptive pooling design, the bounds on the number of
tests obtained below for adaptive pooling design applies for
the non-adaptive pooling design also. The three possible error
events in the first step of the decoding algorithm for both non-
adaptive and adaptive pooling design are given by
1) A defective is not declared as one.
2) A normal item is declared as a defective.
3) An inhibitor is declared as a defective.
Clearly, the defective that has the largest probability of a
negative outcome, given by b1max = max
u
(
1− q(u)1
)
, has
the largest probability of not being declared as a defective.
So, with T1 = β1 log n, the probability of the first error event
for all the defectives can be upper bounded (using the union
bound over all defectives) as
9d
T1∑
t=0
(
T1
t
)
pt1(1− p1)T1−t
t∑
v=tbmax(1+τ)
(
t
v
)
bv1max(1− b1max)t−v
= d
T1∑
t=0
(
T1
t
)
pt1(1− p1)T1−t ×
t∑
v=tb1max+t(bmax−b1max+bmaxτ)
(
t
v
)
bv1max(1− b1max)t−v
(a)
≤ d
T1∑
t=0
(
T1
t
)
pt1e
−2t(bmax−b1max+bmaxτ)2(1− p1)T1−t
(b)
= d
[
1− p1 + p1e−2(bmax−b1max+bmaxτ)
2
]β1 logn
(c)
≤ d exp
{
−β1p1 logn
(
1− e−2(bmax−b1max+bmaxτ)2
)}
≤ n−δ1
(d)⇐ d exp{−β1p1 logn (1− e−2) (bmax − b1max + bmaxτ)2}
≤ n−δ1
⇒ β1 ≥
(
ln d
lnn
+ δ1
)
ln 2
p1(1− e−2)(bmax − b1max + bmaxτ)2
,
where (a) follows from Chernoff-Hoeffding bound [24]3, (b)
follows from binomial expansion, (c) follows from the fact that
1−c ≤ e−c, and (d) follows from the fact that
(
1− e−2x2
)
≥(
1− e−2)x2, for 0 < x < 1. Using the fact that b1max ≤
bmax, where bmax is defined in (6), the following bound on
β1 suffices.
β1 ≥
(
ln d
lnn + δ1
)
ln 2
p1(1− e−2)(bmaxτ)2 . (7)
Similarly, to guarantee vanishing probability for the second
error event (union-bounded over all normal items) and the third
error event (union-bounded over all inhibitors), it suffices that
β1 ≥
(
ln(n−d−r)
lnn + δ1
)
ln 2
p1(1− e−2) (1− bmax(1 + τ)− q2)2
,
β1 ≥
(
ln r
lnn + δ1
)
ln 2
p1(1− e−2)
(
1− bmax(1 + τ)− q(s)3
)2 , (8)
Since max
s
q
(s)
3 ≤ q2 and r = o(n), the bound in (8) is
asymptotically redundant for all values of τ . So, substituting
the upper bound on q2 defined in (4) by qUB2 , it suffices that
β1 ≥
(
ln(n−d−r)
lnn + δ1
)
ln 2
p1(1− e−2)
(
1− bmax(1 + τ)− qUB2
)2 (9)
Now, the value of τ chosen to optimize the denominators of
(7) and (9) is given by τ = 1−bmax−q
(UB)
2
2bmax
. Therefore, we have
β1 ≥max
{
4
(
ln d
lnn + δ1
)
ln 2
p1(1− e−2)
(
1− bmax − qUB2
)2 , (10)
4
(
ln(n−d−r)
lnn + δ1
)
ln 2
p1(1− e−2)
(
1− bmax − qUB2
)2
 .
3If the term bmax(1 + τ) > 1, then the probability of the error event under
consideration is equal to zero. So, it can be assumed that bmax(1 + τ) ≤ 1.
The term 1− bmax − q2 can be lower bounded as follows.
1− bmax − q2 ≥ (1− p1)Imax − (1− (1− p1)d)
≥ 1− (Imax + d)p1.
The last lower bound above follows from the fact that
(1− p1)Imax ≥ (1− Imaxp1) and (1 − p1)d ≥ (1 − dp1).
Optimizing the denominator terms of (10) with respect to p1,
we have p1 = 13(Imax+d) . Hence, using r, d = o(n) in (10),
for sufficiently large n it suffices that
βNA, β1 ≥
27 (Imax + d)
(
ln(n−d−r)
lnn + δ1
)
ln 2
(1− e−2) , (11)
where TNA = βNA log n.
2) Error Analysis of the Second Step: In the error analysis
of the second step, we assume that all the defectives have
been correctly declared. Errors due to error propagation from
the first step shall be analyzed later.
Non-adaptive pooling design:
The only error event for the non-adaptive pooling design in
the second step is that there does not exist a set of pools
Pk such that they contain only the defective uk and none of
its associated inhibitors I(uk), and all its non-associated items
appear in at least one of such pools. Denote this error event by
U (uk). Clearly, none of the inhibitors associated with uk will
be declared as non-associated with uk. This follows from the
definition of the set of pools Pk and the decoding algorithm.
The probability of the favourable event that a non-associated
item appears along with a defective uk, but none of its
associated inhibitors and none of the other defectives appear
in a pool from MNA is given by
b(uk) , p21(1− p1)|I(uk)|(1− p1)d−1.
Now, probability of the error event U (uk) is upper bounded
by
Pr{U (uk)} ≤ (n− d− |I(uk)|)
(
1− b(uk)
)TNA
≤ (n− d− |I(uk)|)e−TNAb(uk) ≤ n−δ2 , if
βNA ≥
(
ln(n−d−|I(uk)|)
lnn + δ2
)
ln 2
b(uk)
.
Since (1 − p1)|I(uk)| ≥ (1 − p1)Imax ≥ (1 − Imaxp1) and
(1− p1)d−1 ≥ (1− dp1), substituting for p1, it suffices that
βNA ≥ 81
4
(Imax + d)
2
(
ln(n− d)
lnn
+ δ2
)
ln 2. (12)
Adaptive pooling design:
Like in non-adaptive pooling design the only error event,
denoted by E (uk), is that items wj not associated with uk are
declared as associated inhibitors, i.e., the item wk does not
appear in any of the positive outcome tests S(yuk). Clearly,
none of the inhibitors associated with uk will be declared as
non-associated with uk.
Let T2 = β2 log n. The number of tests required to guar-
antee vanishing error probability for the error event E (uk) is
evaluated as follows. Let wj /∈ I(uk). Define
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a(uk)wj , Pr
{
yuk(l) = 1 | wj is present in lth-test
}
≥ (1− p2)|I(uk)| , a(uk).
Now, we have
Pr {E (uk)} ≤ (n− d− |I(uk)|)
(
1− a(uk)p2
)T2 ≤ n−δ2
⇐ β2 ≥
(
ln(n−d−|I(uk)|)
lnn + δ2
)
ln 2
p2 (1− p2)|I(uk)|
.
Using the fact that (1− p2)|I(uk)| ≥ 1 − |I(uk)|p2, and
substituting p2 = 12Imax , we have the following bound.
β2 ≥ 4Imax
(
ln (n− d− |I(uk)|)
lnn
+ δ2
)
ln 2
⇐ β2 ≥ 4Imax
(
ln (n− d)
lnn
+ δ2
)
ln 2. (13)
3) Analysis of Total Error Probability: Assuming that the
target total error probability is O(n−δ), the values of δ1 and δ2
need to be determined. Towards that end, define the following
events.
Eij , Event of declaring (wi, wj), i 6= j, to be an associated
pair,
W , Event that at least one actual defective has not been
declared as a defective.
Let E denote the correct association pattern for some realiza-
tion {I,D}. Now, the total probability of error is given by
Pr
 ⋃
(wi,wj)/∈E
Eij
⋃
W
 ≤ ∑
(wi,wj)/∈E
Pr {Eij}+ Pr {W }
≤
∑
wi 6=wj
∑
wj∈N∪I
Pr {Eij}+
∑
wi /∈I(wj)
∑
wj∈D
Pr {Eij} (14)
+ Pr {W }
<n× 2n−δ1 + dn−δ2 + n−δ1 . (15)
There are two possible ways in which the event Eij , for
(wi, wj) /∈ E , can occur. One possibility is that the item
wj has been erroneously declared as a defective in the first
step of the algorithm, and hence any item wi declared to
be associated with wj is an erroneous association. The first
term in (14) represents this possibility. The other possibility
is that wj has been correctly identified as a defective, but the
item wi is erroneously declared to be associated with wj . The
second term in (14) represents this possibility. The last term
accounts for the fact that a defective might be missed out in
the first step of the algorithm. Note that the other two terms
do not capture this error event. Finally, (15) follows from the
error analysis of the first and second steps of the decoding
algorithm. Therefore, if the target error probability is O(n−δ),
then choose δ1, δ2 = δ + 1.
Recall that the number of tests required for non-adaptive
and adaptive pooling designs are given by TNA = βNA log n
and TA = T1 + dT2 = (β1 + dβ2) log n respectively.
Therefore, from (11), (12), and (13) we have that TNA =
O
(
(Imax + d)
2 log n
)
and TA = O (Imaxd log n).
B. Adaptation for the IDG-NSI Model
The only modification required in the pooling design and
decoding algorithm proposed for the IDG-WSI model to adapt
it for the IDG-NSI model is that Imax is replaced by r. For
the sake of clarity, we list the only changes below.
1) The pooling design parameters are chosen as p = p1 =
1
3(r+d) , p2 =
1
2r .
2) In Step 1 of the decoding algorithm the threshold for
identifying the defectives is chosen as |Swj (y1)| >
|Twj (y1)|[1−bmax(1+τ))], where bmax = 1−(1−p1)r.
Intuitively, this worst-case threshold corresponds to a
scenario where every inhibitor inhibits every defective,
i.e., the 1-inhibitor model.
3) The values of βNA, β1 and β2 are chosen as
βNA ≥max
27 (r + d)
(
ln(n−d−r)
lnn + δ1
)
ln 2
(1− e−2) ,
81
4
(r + d)2
(
ln(n− d)
lnn
+ δ2
)
ln 2
}
,
β1 ≥
27 (r + d)
(
ln(n−d−r)
lnn + δ1
)
ln 2
(1− e−2) ,
β2 ≥4r
(
ln (n− d)
lnn
+ δ2
)
ln 2.
Hence, the total number of tests required for the IDG-NSI
model scales as TNA = O
(
(r + d)2 log n
)
for the non-
adaptive pooling design and TA = O(rd log n) for the two-
stage adaptive pooling design.
In the next section, lower bounds on the number of tests for
non-adaptive and adaptive pooling designs are obtained.
IV. LOWER BOUNDS FOR NON-ADAPTIVE AND ADAPTIVE
POOLING DESIGN
In this section, two lower bounds on the number of tests
required for non-adaptive pooling designs for solving the IDG-
NSI and IDG-WSI problems with vanishing error probability
are obtained. One of the lower bounds is simply obtained
by counting the entropy in the system and this lower bound
also holds good for adaptive pooling designs. The other lower
bound is obtained using a lower bound result for the 1-inhibitor
model which is stated below. We recall that all the inhibitors
inhibit the expression of every defective in the 1-inhibitor
model.
Theorem 3 (Th. 1, [13]): An asymptotic lower bound on
the number of tests required for non-adaptive pooling designs
in order to classify r inhibitors amidst d defectives and
n − d normal items in the 1-inhibitor model is given by
Ω
(
r2
d log rd
log n
)
, in the d = o(r), r = o(n) regime4.
The second lower bound in the following theorem dominates
in the large inhibitor regime, i.e., the number of inhibitors
is large compared to the number of defectives. It conveys
4Though Theorem 1 in [13] is stated for the classification of both the defec-
tives and inhibitors in the 1-inhibitor model, it is also valid for classification
of inhibitors alone. This is because the entropy in the system is dominated
by the number of inhibitors, in the large inhibitor regime.
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the number of tests required to identify the inhibitors alone.
Though the inhibitors outnumber the defectives, they can be
identified only in the presence of an associated defective. So,
the worst scenario (in terms of number of tests) happens when
most inhibitors have to be identified using a single defective,
or in other words, all of the inhibitors happen to inhibit
a single defective. The third lower bound in the following
theorem exploits the intuition gained from Step 2 of the
decoding algorithm for non-adaptive pooling design (given in
Section III). This lower bound is obtained by characterizing the
minimum number of tests required to identify the associations
of every defective. Since no two defectives might be associated
with a single inhibitor, it is necessary that no two defectives
participate in the same test from which the associations
of a defective are identified. Otherwise, the non-associated
defective masks the effect of association of the associated
inhibitor-defective pair. This might result in wrongly declaring
the associated inhibitor-defective pair to be non-associated.
Throughout this section, lowercase alphabets are used for
defectives and inhibitors whose realizations are revealed by
a genie and uppercase alphabets are used for those whose
realizations are unknown.
Theorem 4: An asymptotic lower bound on the number of
tests required for non-adaptive pooling designs for solving the
IDG-NSI problem with vanishing error probability for r, d =
o(n) is given by
max
{
Ω ((r + d) log n+ rd) ,Ω
(
r2
log r
log n
)
,Ω(d2)
}
.
Proof: The proof for the first lower bound on the number
of tests follows by lower bounding the total number of possible
realizations of the sets of inhibitors, defectives, and association
patterns.
TNA ≥ H (I,D, E(I,D))
= H(D) +H (I|D) +H(E(I,D)|(I,D)) (16)
= log
(n
d
)(
n− d
r
) d∑
i1=1
· · ·
d∑
ir=1
r∏
j=1
(
d
ij
)
≥ log
((
n
d
)(
n− d
r
) r∏
k=1
(
d
d
2
))
= Ω ((r + d) log n+ rd) , (17)
where ij denotes the number of defectives that the jth-inhibitor
can be associated with, and the last step follows by using
Stirling’s lower bound
(
d
d
2
) ≥ 2 d2 . This lower bound on the
number of tests is also valid for adaptive pooling designs.
The second lower bound for non-adaptive pooling designs is
obtained as follows. Assume that it is required to identify the
inhibitors alone. Clearly, this requires lesser number of tests
than the problem of identifying the association graph. Since
the objective is to satisfy the error metric in (1), the error
probability criterion
Pr
{
Iˆ 6= I
}
≤ cn−δ (18)
has to be satisfied for all possible association patterns E
on all possible realizations of (I,D). Let PD-DA denote
a pooling design, decoding algorithm tuple that satisfies
(18), and P denotes the set of all such tuples. Further, let
TNA(PD-DA, I,D, E) denote the minimum number of tests
required by PD-DA to satisfy (18) for a particular realization
of (I,D, E). We now have to determine the lower bound
inf
P
sup
(I,D,E)
TNA. We now have
inf
P
sup
(I,D,E)
TNA ≥ inf
P
sup
(I,D,E′)
TNA,
where E ′ denotes a specific class of association pattern repre-
sented in Fig. 6. Now, assume that a genie reveals the set of
Fig. 6: The class of association pattern used to obtain the
second lower bound, illustrated for some realization of (I,D).
A single defective is associated with all the inhibitors, but none
of the other defectives are associated with any inhibitor.
defectives D ′ , {u2, · · · , ud} which are not associated with
any of the inhibitors. A lower bound for this problem with
side information from the genie is clearly a lower bound for
the original problem. A lower bound on the number of tests
T ′NA for this problem is given by [13]
5
T ′NA∑
l=1
H[y(l)] = Ω
(
log
(
n− d
r
))
.
Note that the presence of any defective from the set D ′ in a
pool always gives a positive outcome, and hence provides zero
information for distinguishing the inhibitors from the rest of
the items as the entropy of such an outcome is zero. So, we
assume that none of the tests contain items from the set D ′.
Therefore, the inhibitor identification problem for items with
the association pattern as given in Fig. 6 is now reduced to
the problem of identifying r inhibitors amidst n − d normal
items and one defective item in the 1-inhibitor model, where
d = o(n). For this problem, using Theorem 3, it follows
that the lower bound on the number of tests is given by
T ′NA = Ω
(
r2
log r log n
)
. Hence, this is also a lower bound on
the number of tests required to identify the association graph
with vanishing worst case error probability.
5A similar expression is used to obtain Theorem 3. This is derived formally
using Fano’s inequality. The steps involved are illustrated in the proof of the
third lower bound.
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The evaluation of the third lower bound is involved and is
obtained as follows. Since the second lower bound is tighter
when r ≥ d, here we assume that r < d. Using similar
arguments as in the second lower bound, a lower bound on the
number of tests for the following reduced problem is a lower
bound for the original problem. Let {S2, · · · , Sr} denote a
set of inhibitors associated with exactly one defective Ud. The
defective Ud is not inhibited by the inhibitor S1. Further, the
inhibitor S1 is associated with exactly one of the defectives
{U1, · · · , Ud−1}. This association graph is depicted in Fig. 7.
Let a genie reveal the set of inhibitors I−S1 , {s2, · · · , sr}
Fig. 7: A possible association graph, where r − 1 inhibitors
and a single defective are associated only among themselves.
The remaining inhibitor is associated with exactly one of the
remaining defectives.
and the defective ud. The “residual message” in the system
is now given by W ′ , {S1,D−ud , E (S1,D−ud)}, where
D−ud , D\ud.
For the reduced problem, we have
max
S1,D−ud ,
E(S1,D−ud)
Pr
{(
Sˆ1, Dˆ−ud , Eˆ
(
Sˆ1, Dˆ−ud
))
(19)
6= (S1,D−ud , E (S1,D−ud))}
≥ Ef
[
Pr
{(
Sˆ1, Dˆ−ud , Eˆ
(
Sˆ1, Dˆ−ud
))
(20)
6= (S1,D−ud , E (S1,D−ud))}] , Peavg ,
where f denotes a probability mass function of the association
graph such that
Pr{(s1, u) ∈ E (s1,D−ud)} =
1
d− 1 , u ∈ D−ud , (21)
Pr{s1,D−ud} =
1(
n−r
d−1
)
(n− r − d+ 1)
for any realization of (S1,D−ud) given by (s1,D−ud). So,
a lower bound on the number of tests required to achieve
vanishing average error probability Peavg in (20) is also a
lower bound on the number of tests required to achieve
vanishing maximum error probability in (19). These in turn
give a lower bound on the number of tests for the original
problem.
Using Fano’s inequality, we have6
H[E (S1,D−ud) |S1,D−ud ,I−S1 , ud]
=
1(
n−r
d−1
)
(n− r − d+ 1)
∑
S1,D−ud
log(d− 1) = log(d− 1)
(22)
≤ 1 + PeH[E (S1,D−ud) |S1,D−ud ,I−S1 , ud]
+ I [E (S1,D−ud) ;y|S1,D−ud ,I−S1 , ud]
≤ 1 + Pe log(d− 1) +H [y|S1,D−ud ,I−S1 , ud] , (23)
where (22) is obtained using (21), and Pe ,
Pr{Eˆ (S1,D−ud) 6= E (S1,D−ud)} ≤ Peavg denotes the
average error probability in declaring the residual association
pattern7. The summation term in (22) denotes summation
over all possible realizations of S1,D−ud . Using the fact that
conditioning reduces entropy in (23), we have
TNA∑
l=1
H [y(l)|S1,D−ud ,I−S1 , ud]
≥ (1− Pe) log(d− 1)− 1. (24)
The presence of items from the set {I−S1 , ud} in a test can
either reduce the entropy or leave the entropy of the test
outcome unaffected. So, we consider only pooling designs that
do not contain any item from the set {I−S1 , ud}. Therefore,
the entropy of a test is dependent only on the realization of
S1,D\ud, i.e.,
H [y(l)|S1,D−ud ,I−S1 , ud]
=H [y(l)|S1,D−ud ]
=
∑
S1,D−ud
Pr {s1,D−ud}H [y(l)|s1,D−ud ] .
Suppose that we are given a pool of gl items for the lth test.
The entropy of the lth test outcome is non-zero only for those
realizations of S1,D\ud for which the lth pool contains exactly
one defective and the inhibitor. This is because, otherwise,
there is no randomness in the test outcome. There are gl(gl−
1)
(
n−r−gl
d−2
)
such possible realizations for 2 ≤ gl ≤ (n − r −
d+ 2), and none for gl = 0, 1 and for gl > (n− r − d+ 2).
For each of these realizations, with 2 ≤ gl ≤ n − r − d + 2,
the entropy of the test outcome is given by
h , 1
d− 1 log(d− 1) +
d− 2
d− 1 log
(
d− 1
d− 2
)
.
6For brevity, we omit the conditioning on E (I−S1 , ud), which is also
revealed by the genie, in the entropy and mutual information terms.
7The inequality holds because E
[
I
(
Eˆ (S1,D−ud) 6= E (S1,D−ud))]
≤ E
[
I
((
Sˆ1, Dˆ−ud , Eˆ
(
S1,D−ud
)) 6= (S1,D−ud , E (S1,D−ud)))],
where E[.] and I(.) represent the expectation operator and the indicator
function respectively.
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Therefore, we have
H [y(l)|S1,D−ud ]
=
1(
n−r
d−1
)
(n− r − d+ 1)gl(gl − 1)
(
n− r − gl
d− 2
)
h
<
1(
n−r
d−1
)
(n− r − d+ 1)g
2
l
(
n− r − gl
d− 2
)
h. (25)
The term dependent on gl is re-written as
g2l
(
n− r − gl
d− 2
)
=
1
(d− 2)!f(gl),
where
f(gl) , g2l
d−3∏
j=0
(n− r − gl − j).
We now maximize the above term with respect to gl ∈ [2, n−
r − d + 2] to obtain a lower bound on the number of tests.
The following lemma gives the approximate optimum value
of gl (denoted by gopt). It is shown that f(gl) > f(gl + )
for all gl ≥ gopt and 0 <  ≤ 1, and f(gl − ) < f(gl) for
all gl ≤ gopt. Since gopt is independent of l, hereupon the
subscript l is dropped. It must be noted that (g+ ), (g− ) ∈
[2, n− r − d+ 2].
Lemma 1: There exists n0 so that for all n ≥ n0, the opti-
mum value of g that maximizes f(g) is given by gopt , 2nd +k,
where k = o
(
2n
d
)
.
Proof: To ensure f(g) > f(g + ) for all g ≥ 2nd−2 , g1
and 0 <  ≤ 1, it suffices that
g2
d−3∏
j=0
(n− r − g − j) > (g + )2
d−3∏
j=0
(n− r − g − − j)
⇔
d−3∏
j=0
(
1 +

n− r − g − − j
)
>
(
1 +

g
)2
⇐
(
1 +

n− r − g − 
)d−2
>
(
1 +

g
)2
⇐
(
1 +

n− r − g − 
)d−2
> e
2
g
⇔g(d− 2)
2
ln
(
1 +

n− r − g − 
)
> 1 (26)
Since the above function is increasing in g, it is sufficient to
prove that the above inequality is satisfied for g = g1. Note
that, since r = o(n) and d −→
n→∞ ∞, we have n − r − g1 =
Ω(n). So, in order to satisfy (26) for all n ≥ n0 and some
finite positive integer n0 at g = g1, it suffices that
1
1− 2d−2 − 2n
> 1,
which is true. The above inequality follows by using the
approximation ln(1 + x) ∼ x in (26), for x << 1.
To ensure f(g − ) < f(g) for all g ≤ 2nd − 4 , g2, it is
required that
(g − )2
d−3∏
j=0
(n− r − g + − j) < g2
d−3∏
j=0
(n− r − g − j)
(27)
⇔
d−3∏
j=0
(
1 +

n− r − g − j
)
<
(
1 +

g − 
)2
⇐
(
1 +

n− r − g − d+ 3
)d−2
<
(
1 +

g − 
)2
⇐ exp
(
(d− 2)
n− r − g − d+ 3
)
<
(
1 +

g − 
)2
⇔
2(n− r − g − d+ 3) ln
(
1 + g−
)
(d− 2) > 1. (28)
Since the above function is decreasing in g, it is sufficient to
prove that the above inequality is satisfied for g = g2. In order
to satisfy (28) for all n ≥ n0 and some finite positive integer
n0 at g = g2, it suffices that
2(n− r − g2 − d+ 3)
(g2 − ) (d− 2) > 1 (29)
⇔ (1−
r
n − 2d − dn + 7n )(
1− d(4+)2n
) (
1− 2d
) > 1
⇔ (1−
r
n − 2d − dn + 7n )
1− 2d − 2d+0.5n + 4+n
> 1,
which is true because r < d8. The inequality (29) is obtained
by using the approximation ln(1+x) ∼ x in (28), for x << 1.
Therefore, we have gopt ∈
[
2n
d − 4, 2nd−2
]
, and so gopt =
2n
d + k, for k = o
(
2n
d
)
.
From (25) and (24), using the approximation h ≈ 1d log d, an
asymptotic lower bound on the number of tests for vanishing
error probability is given by
TNA ≥ Ω
(
d
(
n−r
d−1
)
(n− r − d+ 1)
g2opt
(
n−r−gopt
d−2
) ) . (30)
We now show that the fractional term above scales as d.(
n−r
d−1
)
(n− r − d+ 1)
g2opt
(
n−r−gopt
d−2
) ≈ (n−rd−1)(n− r − d+ 1)
4n2
d2
(
n−r−gopt
d−2
)
=
∏d−2
i=0 (n− r − i)(n− r − d+ 1)
4n2
d2 (d− 1)
∏d−3
i=0 (n− r − gopt − i)
≈d
4
d−3∏
i=0
n− r − i
n− r − gopt − i (31)
=
d
4
d−3∏
i=0
(
1 +
gopt
n− r − gopt − i
)
≥d
4
(
1 +
gopt
n− r − gopt
)d−2
≈ d
4
e
gopt(d−2)
n−r−gopt ≈ de
2
4
. (32)
8Recall that this was assumed at the beginning of the proof of the third
lower bound.
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It must be noted that the ratio notion of approximation does not
affect the scaling of the number of tests. The approximations
in (31) and (32) make use of the fact that r, d = o(n) and
gopt =
2n
d + o
(
2n
d
)
. Therefore, from (30) and (32), we have
TNA = Ω(d
2).
The lower bounds for the IDG-WSI model are obtained in
the following theorem. Since we are interested in asymptotic
lower bounds, we assume that the limits lim
n→∞
Imax
r and
lim
n→∞
r
dImax
exist, and Imax −→
n→∞∞. The ideas used to obtain
the following theorem are similar to those used in Theorem 4.
However, the “second constraint” (mentioned in the proof of
the following theorem) needs to be accounted for.
Theorem 5: An asymptotic lower bound on the number of
tests required for non-adaptive pooling designs for solving the
IDG-WSI problem with vanishing error probability for r, d =
o(n) is given by
max
{
Ω ((r + d) log n+ Imaxd) ,Ω
(
I2max
log Imax
log n
)}
.
An additional asymptotic lower bound is given by Ω(d2) when
either 1) r = (c− 1)d+ kd, for some constant 0 < k < 1 and
Imax = c or 2) r = (c− 1)d+ k and (c− 1)d < r ≤ cd, for
positive integer k = o(d) and Imax = c or 3) (c− 1)d < r ≤
cd and Imax ≥ c+ 1.
Proof: The first lower bound is obtained by lower bound-
ing H (E(I,D)|(I,D)) in (16) as follows. Two constraints
need to be satisfied while counting the entropy of association
pattern.
• First constraint: Minimum degree of a vertex in I is one.
• Second constraint: Maximum degree of a vertex in D is
no more than Imax.
We now consider the three possible cases below and show
that in each of the cases the lower bound on the number
of association patterns scales exponentially in Imaxd. Let
(c− 1)d < r ≤ cd, for some positive integer c, and so Imax ≥
c. Define α1 = lim
n→∞
c
Imax
and α2 = lim
n→∞
Imax
r .
Case 1: α1 < 1 and α2 < 1. There exist positive constants
β1 < 1 and β2 < 1 so that c ≤ β1Imax and Imax ≤ β2r, ∀n ≥
n0. Define an association pattern, where each defective starting
from u1 is assigned a disjoint set of c inhibitors until every
inhibitor is covered. Therefore we have, max
ui∈D
|I(ui)| ≤ c.
Since the first constraint is satisfied, each defective is now free
to choose an association pattern so that max
ui∈D
|I(ui)| ≤ Imax.
The number of such possible association patterns can be lower
bounded by(
r
Imax − c
)d
≥
(
r
Imax − c
)(Imax−c)d
.
Thus, the entropy of association pattern in this case scales
(asymptotically) as the logarithm of the above quantity, which
is given by Ω(Imaxd).
Case 2: α1 < 1 and α2 = 1. There exist positive constants
β1 < 1 and β2 ≤ 1 with β2 > β1 so that c ≤ β1Imax and
Imax ≥ β2r, ∀n ≥ n0. So, we have Imax − c ≥ (β2 − β1)r,
∀n ≥ n0. Using similar arguments as in Case 1, where after
satisfying the first constraint, β2r− c inhibitors are chosen to
associate with each defective, we now have that the entropy
of association pattern in this case scales asymptotically as
Ω(rd) = Ω(Imaxd).
Case 3: α1 = 1. Note that this case constitutes a large
inhibitor regime with respect to the number of defectives
(because Imax →∞). There exists a positive constant β1 ≤ 1
so that c ≥ β1Imax, ∀n ≥ n0. The number of ways of
assigning each defective to a disjoint set of (c− 1) inhibitors
is given by
(
r
c− 1
)(
r − (c− 1)
(c− 1)
)(
r − 2(c− 1)
(c− 1)
)
· · ·
(
r − (d− 1)(c− 1)
(c− 1)
)
=
r!
((c− 1)!)d(r − d(c− 1))!
≥
(a)
√
2pirr+
1
2 e−r
e2(c− 1)d(c−1+ 12 )e−d(c−1)(r − d(c− 1))r−d(c−1)+ 12 e−(r−d(c−1))
≥
(b)
√
2pi(d(c− 1))d(c−1)+ 12 e−dc
e2(c− 1)d(c−1+ 12 )e−d(c−1)(r − d(c− 1))r−d(c−1)+ 12 e−(r−d(c−1))
≥
(c)
√
2pi(d(c− 1))d(c−1)+ 12 e−dc
e2(c− 1)d(c−1+ 12 )e−d(c−1)dd+ 12
=
√
2pi(c− 1) 12 dd(c−2)
e2(c− 1) d2 ed
=
√
2pi(c− 1) 12 dd(c−2)
e2d d logd(c−1)
2
dd logd e
=
√
2pi
e2
(c− 1) 12 dd
(
c− logd(c−1)
2
−logd e−2
)
,
where (a) follows from Stirling’s lower and upper bounds for
factorial functions, (b) and (c) follow from the fact that d(c−
1) < r ≤ cd. Observe that the remaining r−d(c−1) inhibitors
can be assigned one each to one defective without violating
the second constraint. Thus, the entropy of association pattern
in this case scales asymptotically as Ω(cd) = Ω(β1Imaxd) =
Ω(Imaxd).
Fig. 8: A possible association pattern where, without loss of
generality, u1 is assumed to be a defective for which |I(u1)| =
Imax. The set of inhibitors and defectives that are associated
only among themselves (which the genie reveals) are inside
the dotted ellipse.
The second lower bound is obtained as shown below. There
could exist at least one defective u1 ∈ D so that |I(u1)| =
15
Imax. Consider an association pattern where I(u1)∩I(uk) =
{∅}, for uk ∈ D, k 6= 1, as depicted in Fig. 8. Now, we use a
similar argument as in the proof of the second lower bound in
Theorem 4. Let a genie reveal the inhibitor subset I −I(u1),
the defective subset D−u1 and their associations. Now, none
of the items from the sets I − I(u1) and D − u1 is useful in
distinguishing the inhibitors in the set I(u1) from the unknown
defective and the normal items. This is because the entropy of
an outcome is zero if the test contains some defective from D−
u1 but none of its associated inhibitors (which are only from
the set I − I(u1)) as such a test outcome is always positive.
The entropy of an outcome does not change if any of the
inhibitors I − I(u1) with or without its associated defectives
(which are only from the set D − u1) is present in the test.
Thus, the problem is now reduced to the 1-inhibitor problem
of finding Imax inhibitors amidst n − (r − Imax) − (d − 1)
normal items and one (unknown) defective. A lower bound on
the number of non-adaptive tests for this problem is clearly a
lower bound on the number of tests for the original problem
of determining the association graph for the IDG-WSI model.
Since r, d = o(n) and Imax −→
n→∞ ∞, using Theorem 3, we
get the lower bound Ω
(
I2max
log Imax
log n
)
.
The third lower bound is obtained below for the case where
r = (c − 1)d + kd, for some constant 0 < k < 1 and
Imax = c. The proof for the other two cases mentioned in
the statement of the theorem are similar. Parts of this proof
are similar to the proof of the third lower bound in Theorem 4,
and hence we only point out the differences in this proof. As
in the proof of Theorem 4, we consider a reduced problem as
follows. As depicted in Fig. 9, a specific class of association
graph is considered, where disjoint sets of c − 1 inhibitors
{I1, I2, · · · , Id} are associated with one defective each, i.e.,
each item in the set Ii with |Ii| = c − 1 is associated
with the defective Ui, for i = 1, · · · , d. Each item in the
set of inhibitors Id+1 , {S(c−1)d+1, · · · , S(c−1)d+kd−1} is
associated with one distinct defective with which the sets of
inhibitors {I1, · · · , Ikd−1} are also associated, i.e., S(c−1)d+j
is associated with the defective Uj , for j = 1, · · · , kd−1. The
remaining inhibitor Sr is associated with exactly one of the
defectives in the set DSr , {Ukd, · · · , Ud}. It is now easily
seen that the first constraint is satisfied, and |I(Uj)| ≤ c for
all j, which means that the second constraint is also satisfied.
Now, let a genie reveal the realizations of {I1, I2, · · · , Id+1}
and {U1, · · · , Ukd−1}, given by I , {I1, I2, · · · , Id+1} and
DSr , {u1, · · · , ukd−1} respectively. The association pattern
between them given by E(I ,DSr ) is also revealed.
The “residual message” in the system is now given by W1 ,
{Sr,DSr , E(Sr,DSr ), E({Ikd, · · · , Id},DSr )}. We now show
that determining W1 , E(Sr,DSr ) itself requires order of
d2 tests. It is easy to see that there is no reduction in the
mutual information I
[
W1;y|Sr,DSr ,I ,DSr , E(I ,DSr )
]
if
the items in the set {I1, · · · , Ikd−1, Id+1,DSr} do not par-
ticipate in any of the tests. So, we assume hereon that
these items do not participate in any of the tests, and thus
denote the rest of the items which participate in the tests by
W ′ , N ⋃{Ikd, · · · , Id, Sr}⋃DSr .
For the reduced problem considered, we have
max
W1
Pr
{
Wˆ1 6= W1
}
≥ Ef
[
Pr
{
Wˆ1 6= W1
}]
, Peavg .
where f denotes some probability mass function of the
residual association graph. Let f1 and f2 denote independent
probability mass functions of the residual association patterns
E(sr,Dsr ) and E({Ikd, · · · , Id},Dsr ), for any realization of
(Sr,DSr ) given by (sr,Dsr ). The function f2 is such that
Pr{(sr, u) ∈ E(sr,Dsr )} =
1
d(1− k) + 1 ,∀u ∈ Dsr , (33)
for any realization (sr,Dsr ). Also, it is assumed f is such
that the realizations of (Sr,DSr ) are uniformly distributed
across the rest of the items, i.e., occurrence of every realization
happens with probability 1
(n−r−kd+2d(1−k)+1 )(n−r−d+1)
.
Let M be the test matrix which is known a priori. Also, let
the matrix M1 denote the test matrix M whose columns are
restricted to the items W ′\{Ikd, · · · , Id}, and the matrix M2
denotes the test matrix M whose columns are restricted to the
itemsW ′\{sr}. Denote the “virtual outcome vector” obtained
by testing the items using the matrices M1 and M2 by
y1 (E(sr,Dsr )) and y2 (E({Ikd, · · · , Id},Dsr )) respectively9.
Note that y = y1.y2, i.e., the actual outcome vector is equal
to component-wise Boolean AND of the two virtual outcome
vectors for every realization (sr,Dsr ). Since E(sr,Dsr ) and
E({Ikd, · · · , Id},Dsr ) are statistically independent messages,
using data-processing inequality, we have
I [E(sr,DSr );y|sr,Dsr , {Ikd, · · · , Id}] (34)
≤ I [E(sr,DSr );y1|sr,Dsr ] .
Now, applying Fano’s inequality, we have
H[E(Sr,DSr )|Sr,DSr , {Ikd, · · · , Id}]
=
1(
n−r−kd+2
d(1−k)+1
)
(n− r − d+ 1)
∑
Sr,DSr
log(d(1− k) + 1)
≤ 1 + PeH[E(Sr,DSr )|Sr,DSr , {Ikd, · · · , Id}]
+ I [E(Sr,DSr );y|Sr,DSr , {Ikd, · · · , Id}]
≤ 1 + Pe log(d(1− k) + 1) + 1(n−r−kd+2
d(1−k)+1
)
(n− r − d+ 1)×∑
Sr,DSr
I [E(Sr,DSr );y1|{Sr,DSr} = {sr,Dsr}]
(35)
≤ 1 + Pe log(d(1− k) + 1) + 1(n−r−kd+2
d(1−k)+1
)
(n− r − d+ 1)×∑
Sr,DSr
H [y1|{Sr,DSr} = {sr,Dsr}] ,
where Pe = Pr{Eˆ(Sr,DSr ) 6= E(Sr,DSr )} ≤ Peavg and (35)
follows from (34). Now, following similar steps after (23) in
the proof of Theorem 4, we have the lower bound of Ω((d(1−
k) + 1)2) = Ω(d2) tests.
9The arguments of the virtual outcome vectors denote that the vectors are
functions of their arguments.
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Fig. 9: Association graph with realizations {I1, · · · , Id, Id+1, u1, · · · , ukd−1} considered for obtaining the third lower bound
for the IDG-WSI model. The genie reveals the realizations {I1, · · · , Ikd−1, Id+1} along with their association pattern with the
realizations {u1, · · · , ukd−1}. It also reveals the realizations {Ikd, · · · , Id} which are known to be associated with the unknown
realization of the remaining defectives DSr . It is also known that the unknown inhibitor Sr is associated with exactly one of
the defectives in the set DSr . Such an association graph is chosen so that the constraint Imax = c is not violated.
Thus, in the d = O(Imax) and d = O(r) regimes, the upper
bound on the number of tests for the proposed non-adaptive
pooling design is away from the proposed (second) lower
bound for the IDG-WSI and IDG-NSI models by log Imax and
log r multiplicative factors respectively. In the Imax = o(d)
and r = o(d) regimes, the upper bounds exceed the proposed
(third) lower bounds by log n multiplicative factors for both
the IDG models, with some restrictions on Imax or r in
IDG-WSI model. When these restrictions are removed, the
evaluation of the lower bound might require consideration of
other association graphs like in Fig. 2, as an extension of the
association graph used in proof of the third lower bound in
Theorem 5. But even for the graph in Fig. 2, the optimization
of the entropy over the pool size becomes combinatorially
cumbersome. We thus relegate the evaluation of lower bound
for the unconstrained IDG-WSI model to future work. For
the proposed two-stage adaptive pooling design, the upper
bound on the number of tests is away from the proposed (first)
lower bound by log n multiplicative factors for both the IDG-
WSI and IDG-NSI models in all regimes of the number of
defectives and inhibitors.
V. CONCLUSION
A new generalization of the 1-inhibitor model, termed IDG
model was introduced. In the proposed model, an inhibitor
can inhibit a non-empty subset of the defective set of items.
Probabilistic non-adaptive pooling design and a two-stage
adaptive pooling design were proposed and lower bounds on
the number of tests were identified. Both in the small and
large inhibitor regimes, the upper bound on the number of
tests for the proposed non-adaptive pooling design is shown
to be close to the lower bound, with a difference of logarithmic
multiplicative factors in the number of items.
For the proposed two-stage adaptive pooling design, the
upper bound on the number of tests is close to the lower bound
in all regimes of the number of inhibitors and defectives,
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the difference being logarithmic multiplicative factors in the
number of items.
Future works could include more practical versions of the
IDG model, such as taking the following considerations into
account.
1) Cancellation effect of the normal items on the inhibitors.
2) Partial inhibition of expression of defectives by the
inhibitors, which also naturally embraces the presence of
inhibitors in the semi-quantitative group testing model
[25].
3) Inclusion of the k-inhibitor model, for unknown k, as a
part of the association pattern in the IDG model.
Obtaining lower and upper bounds on the number of tests
for the aforementioned variants of the IDG model along with
inclusion of noisy tests should be more involved and worth
pursuing.
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